HCM
NVS icon

Highbridge Capital Management’s Novartis NVS Stock Holding History

Highbridge Capital Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-55,800
Closed -$3.95M – 1493
2016
Q3 		$3.95M Buy
+55,800
New +$4.07M 0.06% 311

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

Highbridge Capital Management's NVS Position: Q4 2016 in Review

Highbridge Capital Management sold out of Novartis (NVS) in Q4 2016, closing a stake of 55,800 shares — an estimated $3.95M sold.

Highbridge Capital Management first reported a position in NVS in Q3 2016 and held it in 1 quarter. The position peaked at $3.95M in Q3 2016. 904 funds tracked by Wall St. Rank hold NVS as of Q4 2016.

  • Highbridge Capital Management reported no remaining Novartis position as of Q4 2016 after selling out during the quarter.
  • Highbridge Capital Management sold 55,800 Novartis shares in Q4 2016, an estimated $3.95M.
  • Highbridge Capital Management first reported a position in Novartis in Q3 2016 and held it in 1 quarter.
  • Highbridge Capital Management's Novartis position peaked at $3.95M in Q3 2016.
  • 904 funds tracked by Wall St. Rank held Novartis as of Q4 2016.

Based on Highbridge Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.